No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
LLY250117C480000
- 331.45
- 0.000.00%
15min DelayClose Jan 10 16:00 ET
0.00High0.00Low
331.45Open331.45Pre Close0 Volume90 Open Interest480.00Strike Price0.00Turnover0.00%IV1.44%PremiumJan 17, 2025Expiry Date319.90Intrinsic Value100Multiplier4DDays to Expiry11.55Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.50Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Express News | Eli Lilly Sues Thrive Health and Wellness LLC & Valhalla Vitality LLC for Sale of Unapproved Tirzepatide Products- Court Filing
AI Trader Outperformed in 2024. Nvidia, Tesla, and Broadcom Are Some of Its Favorites.
Market Chatter: Eli Lilly Eyes $2.5 Billion Deal for Scorpion Therapeutics
Eli Lilly (NYSE:LLY) Shareholders Have Earned a 44% CAGR Over the Last Five Years
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
Key Deals This Week: FuboTV - Disney, Constellation Energy, Eli Lilly, Phillips 66, Intercontinental Exchange and More